In Brief: Schering-Plough
This article was originally published in The Tan Sheet
Executive Summary
Schering-Plough: Submits April 30 comments on FDA's March 4 proposed rule on interchangeable terms for OTC labels ("The Tan Sheet" March 4, In Brief) requesting that the term "podiatrist" be considered interchangeable with the word "doctor" or "physician" on OTC foot care product labeling. Schering markets Lotrimin AF Antifungal and Tinactin preparations for athlete's foot and Duofilm wart treatment...